Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › COOPERSTOWN › MARY IMOGENE BASSETT HOSPITAL

MARY IMOGENE BASSETT HOSPITAL

NPI: 1780600577 · COOPERSTOWN, NY 13326 · Rural Acute Care Hospital · NPI assigned 07/14/2006

$121.76M
Total Medicaid Paid
1,853,705
Total Claims
1,662,008
Beneficiaries
545
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSWINKO, PAUL (BASSETT MEDICAL CENTER VP)
NPI Enumeration Date07/14/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,431 $28K
2019 108,351 $5.94M
2020 307,845 $17.19M
2021 383,329 $21.67M
2022 379,257 $33.80M
2023 380,072 $25.58M
2024 293,420 $17.56M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 156,914 140,506 $21.99M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 134,785 122,018 $18.52M
G9005 Coordinated care fee, risk adjusted maintenance 38,415 38,415 $11.69M
99215 Prolong outpt/office vis 34,298 32,622 $4.86M
80053 Comprehensive metabolic panel 47,467 43,584 $2.45M
Q3014 Telehealth originating site facility fee 42,203 35,326 $2.44M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 14,296 14,105 $2.09M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 13,353 13,342 $2.00M
90832 Psychotherapy, 30 minutes with patient 15,699 10,336 $1.95M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 14,541 13,836 $1.86M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 11,543 10,741 $1.77M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 23,907 22,997 $1.72M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1,495 1,484 $1.62M
90834 Psychotherapy, 45 minutes with patient 9,397 6,370 $1.44M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,844 1,832 $1.39M
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 9,401 9,335 $1.31M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 8,936 8,921 $1.29M
99283 Emergency department visit for the evaluation and management, moderate severity 6,681 6,487 $1.27M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,405 2,366 $1.21M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 6,805 6,483 $1.19M
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 8,238 8,185 $1.14M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 24,807 23,183 $1.13M
81025 14,812 14,279 $1.08M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 11,819 11,119 $1.02M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2,523 2,520 $950K
96127 28,067 13,900 $935K
99284 Emergency department visit for the evaluation and management, high severity 4,292 4,134 $777K
20610 2,880 2,767 $756K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 666 661 $700K
80048 Basic metabolic panel (calcium, ionized) 13,313 11,900 $647K
90686 26,833 26,242 $636K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 21,469 16,444 $595K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 773 766 $580K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,218 3,212 $566K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3,710 2,137 $536K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 17,088 17,025 $523K
80061 Lipid panel 27,534 27,398 $517K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 12,599 10,366 $514K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 9,779 9,665 $474K
88305 Level IV - Surgical pathology, gross and microscopic examination 10,377 7,440 $470K
59025 Fetal non-stress test 2,686 1,735 $453K
77067 Screening mammography, bilateral, including computer-aided detection 6,209 6,188 $442K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,829 1,808 $438K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6,511 2,569 $412K
70450 Computed tomography, head or brain; without contrast material 1,066 1,048 $411K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 8,674 7,453 $410K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 55,667 49,374 $401K
17110 1,487 1,377 $400K
86850 4,362 4,043 $362K
96361 Intravenous infusion, hydration; each additional hour 1,715 1,571 $353K
84443 Thyroid stimulating hormone (TSH) 33,202 32,724 $343K
90791 Psychiatric diagnostic evaluation 1,485 1,409 $295K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,433 1,395 $284K
74176 Computed tomography, abdomen and pelvis; without contrast material 537 525 $280K
87507 1,153 1,142 $276K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 5,947 4,991 $274K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 11,911 10,179 $271K
36416 3,083 3,033 $261K
36415 Collection of venous blood by venipuncture 39,087 15,317 $259K
77063 Screening digital breast tomosynthesis, bilateral 5,732 5,698 $249K
90792 Psychiatric diagnostic evaluation with medical services 977 975 $246K
90651 5,536 5,225 $231K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 4,608 4,600 $229K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 2,698 2,592 $228K
90715 8,407 8,367 $221K
76830 Ultrasound, transvaginal 2,137 2,117 $214K
93017 1,115 1,107 $206K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 12,218 11,285 $206K
J1050 Injection, medroxyprogesterone acetate, 1 mg 3,471 3,468 $202K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 2,949 1,652 $202K
76705 Ultrasound, abdominal, real time with image documentation; limited 1,966 1,949 $201K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 287 284 $199K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 7,971 5,645 $198K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 317 317 $194K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 9,766 9,664 $193K
96375 Therapeutic injection; each additional sequential IV push 4,628 3,473 $192K
78815 Positron emission tomography (PET) for limited area imaging 259 259 $190K
52000 103 103 $189K
80051 4,763 4,577 $183K
J9271 Injection, pembrolizumab, 1 mg 16 12 $181K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 5,491 5,479 $174K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 16,420 14,295 $173K
71046 Radiologic examination, chest; 2 views 5,136 5,036 $169K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg 182 181 $169K
76770 866 861 $161K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 2,537 1,921 $158K
90670 7,355 7,335 $157K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 916 644 $148K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 237 235 $147K
73630 3,347 3,189 $147K
90648 6,803 6,791 $139K
73564 2,341 2,285 $139K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 895 778 $138K
73610 2,613 2,440 $137K
93971 983 967 $128K
83036 Hemoglobin; glycosylated (A1C) 22,088 21,932 $125K
90677 2,889 2,884 $124K
76801 1,078 1,058 $122K
94010 1,294 1,282 $122K
92557 2,681 2,374 $119K
76536 1,088 1,086 $117K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 528 522 $115K
90680 5,739 5,727 $112K
92567 3,393 3,373 $104K
90700 4,555 4,547 $103K
G0378 Hospital observation service, per hour 2,217 1,352 $103K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 894 890 $103K
99385 811 807 $103K
72110 1,435 1,424 $103K
97162 933 927 $102K
87634 3,949 3,862 $99K
90633 4,724 4,716 $99K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2,116 611 $97K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 163 162 $97K
82607 9,777 9,687 $96K
87081 14,451 14,108 $92K
99406 3,489 3,447 $92K
71271 291 291 $91K
64493 63 62 $90K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 336 336 $89K
77336 259 114 $89K
90723 4,801 4,783 $89K
86901 4,417 4,091 $89K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 4,303 4,224 $88K
92134 1,552 1,516 $86K
83655 7,245 7,112 $85K
51798 312 307 $84K
73030 2,035 1,959 $82K
82728 7,932 7,653 $81K
84439 9,722 9,577 $78K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4,019 3,810 $76K
87481 1,824 1,796 $75K
85027 13,026 12,342 $74K
71275 Computed tomographic angiography, chest, with contrast material 149 149 $73K
73110 1,736 1,606 $73K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 216 216 $73K
86900 4,421 4,095 $73K
90734 3,229 3,221 $70K
73130 1,161 1,118 $70K
76700 Ultrasound, abdominal, real time with image documentation; complete 365 365 $70K
87086 Culture, bacterial; quantitative colony count, urine 13,693 13,039 $70K
88304 2,142 1,785 $70K
83970 1,762 1,715 $69K
99188 1,106 1,058 $68K
11104 134 134 $67K
71045 Radiologic examination, chest; single view 2,935 2,797 $66K
76642 630 627 $65K
80076 2,086 1,995 $64K
36591 1,889 1,196 $64K
86803 6,273 6,243 $64K
96367 845 532 $63K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2,193 2,150 $60K
82565 7,938 7,716 $60K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 1,585 873 $59K
D9997 1,190 327 $59K
90710 2,843 2,841 $59K
J1756 Injection, iron sucrose, 1 mg 1,067 520 $58K
Q9992 Injection, buprenorphine extended-release (sublocade), greater than 100 mg 26 24 $57K
90750 410 407 $56K
96160 1,263 1,262 $56K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 158 158 $54K
90707 2,336 2,330 $53K
A9585 Injection, gadobutrol, 0.1 ml 2,518 1,520 $53K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 30,200 29,772 $50K
90619 1,750 1,537 $50K
85610 7,333 5,269 $49K
91322 611 610 $49K
71260 Computed tomography, thorax, diagnostic; with contrast material 134 134 $49K
83735 12,056 9,842 $48K
93226 272 270 $48K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 5,451 5,425 $47K
81003 20,668 19,117 $47K
90716 2,137 2,133 $46K
99443 495 389 $46K
90732 952 938 $45K
86580 3,003 2,826 $45K
V2020 Frames, purchases 1,472 1,460 $45K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 760 359 $44K
G0444 Annual depression screening, 5 to 15 minutes 1,148 1,145 $44K
G9001 Coordinated care fee, initial rate 580 580 $44K
84450 6,647 6,524 $42K
87522 Neg quan hep c or qual rna 1,122 1,103 $42K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,232 3,933 $42K
73502 853 840 $41K
88112 212 204 $41K
90837 Psychotherapy, 53 minutes with patient 306 239 $41K
81001 8,767 8,264 $41K
87077 5,406 5,086 $40K
90697 1,759 1,758 $40K
84466 5,716 5,594 $39K
99442 417 368 $39K
95117 569 303 $39K
84460 5,103 5,042 $39K
90656 1,987 1,901 $39K
0001A 1,070 1,068 $39K
A4649 Surgical supply; miscellaneous 1,472 216 $37K
83690 6,438 6,088 $35K
83880 1,134 1,039 $35K
95909 188 188 $35K
86140 5,961 5,754 $34K
69209 631 621 $34K
84484 3,460 2,913 $34K
82746 3,295 3,276 $33K
97161 328 328 $33K
82570 6,631 6,462 $32K
84702 3,216 2,741 $31K
0002A 818 816 $31K
11720 801 782 $31K
92133 560 557 $30K
43235 41 41 $29K
93922 382 379 $29K
96415 76 54 $29K
69210 426 420 $29K
58300 208 205 $29K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 83 65 $28K
73140 590 576 $28K
0071A 772 772 $28K
99381 167 165 $28K
86618 4,212 4,169 $28K
73080 659 612 $27K
74018 862 839 $27K
92587 586 585 $27K
83540 7,079 6,937 $26K
84520 6,171 5,145 $26K
95886 502 502 $26K
84480 3,215 3,171 $26K
82043 5,634 5,600 $25K
42820 Tonsillectomy and adenoidectomy; younger than age 12 12 12 $25K
87070 5,148 4,911 $25K
82948 5,459 3,419 $25K
87653 493 489 $25K
87340 3,591 3,561 $24K
58100 53 53 $24K
0072A 653 653 $24K
96523 475 403 $23K
99383 177 177 $23K
J2469 Injection, palonosetron hcl, 25 mcg 1,378 818 $23K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,255 1,096 $23K
99386 185 185 $23K
71250 41 41 $22K
82330 1,954 1,872 $22K
84403 1,549 1,526 $22K
90620 709 709 $22K
87186 4,545 4,284 $22K
92083 344 341 $21K
84153 2,613 2,590 $21K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 633 630 $21K
70551 Magnetic resonance imaging, brain; without contrast material 51 51 $20K
54150 25 25 $20K
81513 1,850 1,820 $20K
82040 3,207 3,057 $20K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 203 202 $19K
86780 2,760 2,745 $19K
82378 1,296 1,169 $19K
94729 527 526 $18K
17000 85 84 $18K
G0297 Low dose ct scan (ldct) for lung cancer screening 69 69 $18K
93242 121 118 $18K
90747 253 249 $18K
99441 151 141 $18K
85652 6,167 5,987 $18K
64721 13 13 $17K
82947 3,656 3,623 $17K
86762 2,103 2,098 $17K
88307 163 136 $17K
86666 3,789 2,173 $17K
72050 338 337 $17K
0124A 484 484 $16K
96376 1,228 803 $16K
0054A 427 426 $16K
0064A 433 433 $16K
90480 613 613 $15K
11102 30 30 $15K
95908 107 107 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 136 117 $14K
D0120 Periodic oral evaluation - established patient 340 198 $14K
0202U Oncology (prostate), multianalyte, gene expression profiling 249 249 $14K
J2704 Injection, propofol, 10 mg 9,943 9,564 $14K
86480 241 239 $13K
84402 1,119 1,105 $13K
92579 398 397 $13K
90472 Immunization administration, each additional vaccine (list separately) 6,425 6,382 $13K
90713 468 467 $12K
73590 245 222 $12K
84146 970 962 $12K
83001 778 774 $12K
87205 2,690 2,507 $12K
V2103 Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens 374 370 $12K
99384 88 88 $11K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 926 719 $11K
82784 1,547 1,291 $11K
96417 471 282 $11K
72170 363 359 $11K
0134A 298 298 $11K
0051A 289 289 $10K
31575 227 224 $10K
88342 135 116 $10K
87468 370 369 $10K
85018 5,332 4,308 $10K
80306 2,114 2,035 $10K
82247 2,540 2,390 $10K
83516 1,484 1,135 $10K
86753 2,139 2,126 $10K
0004A 274 274 $10K
97035 456 168 $10K
85379 986 966 $9K
11056 38 38 $9K
82248 1,127 1,002 $9K
87476 468 467 $9K
92551 168 41 $9K
90746 360 354 $9K
82950 1,747 1,743 $9K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 270 270 $9K
99382 69 69 $9K
86706 1,241 1,228 $8K
J7120 Ringers lactate infusion, up to 1000 cc 10,277 9,622 $8K
86787 1,723 1,712 $8K
84550 1,860 1,707 $8K
97535 Self-care/home management training, each 15 minutes 231 199 $8K
11721 136 136 $8K
86003 395 392 $8K
83615 2,490 2,253 $8K
73090 231 213 $8K
95816 39 39 $8K
92552 186 186 $8K
88720 1,774 1,300 $8K
83520 1,012 995 $8K
85014 917 843 $7K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 4,937 4,820 $7K
90696 397 397 $7K
86769 271 270 $7K
59430 730 727 $7K
84100 2,104 1,881 $7K
82550 1,307 1,219 $7K
27096 12 12 $7K
J3490 Unclassified drugs 329 318 $7K
90847 Family psychotherapy with the patient present, 50 minutes 38 30 $7K
86431 1,525 1,516 $6K
20550 27 25 $6K
77334 13 12 $6K
87469 371 370 $6K
87478 370 369 $6K
92250 93 92 $6K
94726 38 38 $6K
86704 924 917 $6K
72125 Computed tomography, cervical spine; without contrast material 27 27 $6K
73562 98 96 $6K
82150 1,301 1,279 $6K
87484 370 369 $6K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 29 29 $6K
84132 1,798 1,490 $6K
82533 395 365 $6K
29075 29 26 $6K
86038 1,467 1,446 $6K
86308 657 648 $6K
D1110 Prophylaxis - adult 83 70 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 36 36 $6K
82310 1,927 1,778 $6K
85730 1,448 1,367 $6K
0052A 144 144 $5K
77300 18 15 $5K
J0690 Injection, cefazolin sodium, 500 mg 2,334 2,116 $5K
25600 12 12 $5K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 25 25 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 8,217 7,051 $5K
84155 2,017 1,972 $5K
10060 13 13 $5K
86376 635 633 $5K
87040 581 345 $4K
0011A 119 119 $4K
83605 1,243 1,109 $4K
86617 596 363 $4K
C1769 Guide wire 252 248 $4K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 292 288 $4K
83721 1,123 1,110 $4K
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) 30 30 $4K
77073 79 79 $4K
84425 444 444 $3K
90662 477 473 $3K
83550 1,215 1,193 $3K
90632 111 105 $3K
G0127 Trimming of dystrophic nails, any number 89 78 $3K
0031A 112 110 $3K
84156 979 896 $3K
93246 26 26 $3K
J7030 Infusion, normal saline solution , 1000 cc 6,920 5,387 $3K
84075 1,252 1,236 $3K
87807 611 606 $3K
86235 303 239 $3K
80347 3,691 3,226 $3K
C1898 Lead, pacemaker, other than transvenous vdd single pass 54 52 $3K
J1453 Injection, fosaprepitant, 1 mg 67 41 $3K
J3010 Injection, fentanyl citrate, 0.1 mg 6,803 6,206 $3K
90647 101 101 $3K
83993 155 154 $3K
0081A 89 89 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,611 4,530 $3K
C9290 Injection, bupivacaine liposome, 1 mg 39 39 $2K
80326 3,690 3,225 $2K
86592 955 952 $2K
81329 55 55 $2K
80364 3,690 3,225 $2K
86765 326 325 $2K
11055 14 14 $2K
0154A 80 80 $2K
77065 Tomosynthesis, mammo 24 24 $2K
83002 164 162 $2K
C1760 Closure device, vascular (implantable/insertable) 73 73 $2K
86800 364 362 $2K
82105 512 498 $2K
D0150 Comprehensive oral evaluation - new or established patient 56 25 $2K
82670 133 132 $2K
58301 24 24 $2K
86364 381 380 $2K
0082A 63 63 $2K
81596 71 70 $2K
86039 619 614 $2K
86665 298 165 $2K
J2795 Injection, ropivacaine hydrochloride, 1 mg 1,801 1,593 $2K
97116 49 37 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 4,910 2,783 $2K
93880 12 12 $2K
87493 197 192 $2K
99407 68 68 $2K
82274 368 367 $2K
81511 39 39 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 7,279 6,643 $2K
76882 29 28 $2K
94761 282 202 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 39 39 $2K
92341 25 25 $2K
67028 Intravitreal injection of a pharmacologic agent 12 12 $2K
72082 25 25 $1K
90685 76 74 $1K
J7050 Infusion, normal saline solution, 250 cc 2,661 1,906 $1K
84165 557 544 $1K
82977 275 253 $1K
80164 118 113 $1K
90381 53 53 $1K
C1887 Catheter, guiding (may include infusion/perfusion capability) 91 83 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 2,972 1,947 $1K
D1206 Topical application of fluoride varnish 42 42 $1K
85045 393 387 $1K
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 921 846 $1K
11200 16 13 $1K
86200 204 204 $1K
84160 558 545 $1K
J1030 Injection, methylprednisolone acetate, 40 mg 345 337 $1K
J2785 Injection, regadenoson, 0.1 mg 38 38 $1K
G0008 Administration of influenza virus vaccine 256 255 $982.79
86870 15 14 $973.53
86708 102 101 $970.21
86664 165 165 $896.46
97530 Therapeutic activities, direct patient contact, each 15 minutes 23 15 $890.52
90744 43 43 $800.07
92340 Fitting of spectacles, except for aphakia; monofocal 13 13 $799.11
72100 15 15 $762.90
J3475 Injection, magnesium sulfate, per 500 mg 1,009 687 $756.74
J2250 Injection, midazolam hydrochloride, per 1 mg 5,417 5,309 $744.41
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 2,200 1,717 $696.11
80349 1,289 1,242 $688.83
J2270 Injection, morphine sulfate, up to 10 mg 1,362 1,067 $638.48
87529 19 15 $628.25
86225 166 166 $623.17
J1170 Injection, hydromorphone, up to 4 mg 1,684 1,502 $613.95
80178 81 79 $607.16
0083A 18 18 $596.68
96411 19 12 $587.07
80377 1,879 1,792 $554.48
0012A 14 14 $491.95
73660 13 13 $488.10
86735 95 86 $470.38
J1644 Injection, heparin sodium, per 1000 units 1,138 705 $468.82
91321 49 49 $455.61
0074A 23 23 $452.01
G0379 Direct admission of patient for hospital observation care 25 24 $433.82
J7042 5% dextrose/normal saline (500 ml = 1 unit) 884 579 $431.89
0053A 12 12 $420.45
V2784 Lens, polycarbonate or equal, any index, per lens 49 49 $396.35
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 555 504 $337.45
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 34 25 $316.51
J2370 Injection, phenylephrine hcl, up to 1 ml 1,118 1,108 $314.86
J1010 Injection, methylprednisolone acetate, 1 mg 139 123 $313.75
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 937 810 $313.47
J0696 Injection, ceftriaxone sodium, per 250 mg 797 610 $305.02
88142 12 12 $295.76
87625 95 95 $292.74
92555 13 13 $286.00
17003 12 12 $281.07
86160 20 13 $274.20
64494 12 12 $262.74
86300 30 25 $245.70
J7060 5% dextrose/water (500 ml = 1 unit) 832 600 $245.28
88302 19 13 $241.15
87075 26 24 $222.43
71101 12 12 $201.95
84481 25 24 $199.37
80329 772 737 $181.14
82272 66 66 $178.58
83883 22 12 $170.80
82374 88 86 $159.61
80177 24 24 $157.45
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,129 851 $155.61
J1650 Injection, enoxaparin sodium, 10 mg 712 373 $140.96
J1598 Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg 227 143 $136.71
84590 25 25 $131.22
84597 13 13 $128.12
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 158 146 $120.98
96380 16 16 $120.90
84295 28 28 $117.53
81015 99 99 $115.04
87102 28 27 $111.63
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units 96 51 $107.21
84446 13 13 $96.82
J1596 Injection, glycopyrrolate, 0.1 mg 148 148 $95.99
80320 1,051 995 $89.94
A9270 Non-covered item or service 348 195 $77.75
84630 13 12 $75.00
84202 12 12 $72.72
86696 12 12 $57.59
86255 16 13 $55.18
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 14 13 $54.66
86695 12 12 $48.85
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 304 264 $46.04
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 84 65 $45.26
82465 16 16 $39.23
J0131 Injection, acetaminophen, not otherwise specified,10 mg 53 51 $38.50
J1171 Injection, hydromorphone, 0.1 mg 36 17 $33.48
J0736 Injection, clindamycin phosphate, 300 mg 22 21 $25.42
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 14 14 $15.81
82435 25 25 $14.66
J2003 Injection, lidocaine hydrochloride, 1 mg 353 305 $14.52
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 88 83 $12.71
94664 66 36 $12.40
87210 12 12 $10.89
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg 15 15 $9.61
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 27 27 $8.37
J2765 Injection, metoclopramide hcl, up to 10 mg 46 41 $5.58
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 37 33 $2.48
J2550 Injection, promethazine hcl, up to 50 mg 14 14 $2.17
99495 24 24 $0.00
92002 12 12 $0.00
80323 29 24 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 51 49 $0.00
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 17 17 $0.00